Evidence map›Paper›PMID 40194518›Full record

ArticleG3 (Bethesda, Md.)2025

In vivo regulation of an endogenously tagged protein by a light-regulated kinase.

Mengjing Bao, Katarzyna Lepeta, Gustavo Aguilar, Sophie Schnider, Markus Affolter, M Alessandra Vigano

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mengjing BaoBiozentrum, University of Basel, Spitalstrasse 41, CH-4056 Basel, Switzerland.
Katarzyna LepetaBiozentrum, University of Basel, Spitalstrasse 41, CH-4056 Basel, Switzerland.
Gustavo AguilarBiozentrum, University of Basel, Spitalstrasse 41, CH-4056 Basel, Switzerland.ORCID 0000-0002-0524-9388
Sophie SchniderBiozentrum, University of Basel, Spitalstrasse 41, CH-4056 Basel, Switzerland.
Markus AffolterBiozentrum, University of Basel, Spitalstrasse 41, CH-4056 Basel, Switzerland.ORCID 0000-0002-5171-0016
M Alessandra ViganoBiozentrum, University of Basel, Spitalstrasse 41, CH-4056 Basel, Switzerland.ORCID 0000-0003-2009-0384

Funding

Kantons Basel-Stadt and Basel-LandSwiss National Science Foundation 310030_192659/1
6 · The paper itself

Abstract

Post-translational modifications (PTMs) are indispensable modulators of protein activity. Most cellular behaviors, from cell division to cytoskeletal organization, are controlled by PTMs, their misregulation being associated with a plethora of human diseases. Traditionally, the role of PTMs has been studied employing biochemical techniques. However, these approaches fall short when studying PTM dynamics in vivo. In recent years, functionalized protein binders have allowed the PTM of endogenous proteins by bringing an enzymatic domain in close proximity to the protein they recognize. To date, most of these methods lack the temporal control necessary to understand the complex effects triggered by PTMs. In this study, we have developed a method to phosphorylate endogenous Myosin in a light-inducible manner. The method relies both on nanobody-targeting and light-inducible activation in order to achieve both tight specificity and temporal control. We demonstrate that this technology is able to disrupt cytoskeletal dynamics during Drosophila embryonic development. Together, our results highlight the potential of combining optogenetics and protein binders for the study of the proteome in multicellular systems.

Indexed as

Drosophila ProteinsLightAnimalsCytoskeletonDrosophilaDrosophila melanogasterHumansMyosinsOptogeneticsPhosphorylationProtein Processing, Post-TranslationalDrosophila ProteinsMyosinsdorsal closureFlyBaselightoptogeneticssynthetic kinase

Identifiers

PMID40194518
PMCPMC12135000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.